27 results
Thumbnail

D1.74 - Molecular IgE sensitization profiling in a patient with Asteraceae weed pollen allergy and anaphylaxis to honey

Thumbnail

D1.75 - Anaphylaxis during Picc Line replacement

Thumbnail

D1.76 - The Hot Chocolate Drink Dilemma

Thumbnail

D1.77 - Perioperative Hypersensitivity Outcomes: A retrospective review of 112 patients seen between 2019 and 2024 at two allergy centres

Thumbnail

D1.78 - Analytical Verification of Omega-5 gliadin (Tri a 19) Allergen Assay on the IMMULITE 2000 XPi System*

Thumbnail

D1.79 - Cardiovascular symptoms during anaphylaxis: An analysis from the European Anaphylaxis Registry

Thumbnail

D1.82 - Diagnostic challenges in amoxicillin-clavulanate anaphylaxis: an inconclusive in vitro study – Case Report

Thumbnail

D1.83 - Asthma and multi-food allergy were risk factors for Oral Food Challenge failure

Thumbnail

D1.84 - IgE-mediated allergy to chlorhexidine: case report

Thumbnail

D1.85 - Basophil activation test in β-Lactam Anaphylaxis: A Case Series from a Tertiary Hospital

Thumbnail

D1.86 - Hypersensitivity Reaction to Lugol’s Solution: A Case Report

Thumbnail

- D3.114 - Does severe asthma exist in preschool children?

Thumbnail

- D3.115 - Outcome and complications of COVID-19 among children with asthma in South Korea: a national incident cohort study

Thumbnail

- D3.116 - Mepolizumab as game changer in a case of severe occupational asthma with rhinitis and contact dermatitis

Thumbnail

- D3.117 - Targeting Mast Cells with Briquilimab, an Anti-Human c-Kit (CD117) Antibody, Mitigates COPD-Like Features in an Allergen and Cigarette Smoke-Exacerbated Asthma Model Using Humanized h/mCD117 Mice

Thumbnail

- D3.118 - Antibiotic Cocktail-Induced Gut Microbiota Dysbiosis Modulates Gut and Airway Immunity, Attenuating Allergic Airway Inflammation

Thumbnail

- D3.119 - Selection of Biologics for Severe Pediatric Asthma with Allergic Eosinophilic Phenotype

Thumbnail

- D3.122 - Management Challenges in Pediatric Asthma with Long QT Syndrome

Thumbnail

- D3.123 - Dupilumab: Improved Asthma Control and Quality of Life in Pediatric Patients - A Real-World, Single-Center Study

Thumbnail

- D3.124 - Severe asthma associated with hereditary angioedema type 1 and other pathologies